Two Sigma Advisers’s Clearside Biomedical CLSD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-62,900
| Closed | -$54.7K | – | 2520 |
|
|
2023
Q3 | $54.7K | Sell |
62,900
-37,200
| -37% | -$32.4K | ﹤0.01% | 2270 |
|
|
2023
Q2 | $112K | Sell |
100,100
-16,100
| -14% | -$18K | ﹤0.01% | 2196 |
|
|
2023
Q1 | $121K | Sell |
116,200
-51,800
| -31% | -$53.9K | ﹤0.01% | 2355 |
|
|
2022
Q4 | $188K | Sell |
168,000
-55,000
| -25% | -$61.6K | ﹤0.01% | 2204 |
|
|
2022
Q3 | $252K | Sell |
223,000
-138,900
| -38% | -$157K | ﹤0.01% | 2124 |
|
|
2022
Q2 | $532K | Sell |
361,900
-296,400
| -45% | -$436K | ﹤0.01% | 1890 |
|
|
2022
Q1 | $1.51M | Sell |
658,300
-221,600
| -25% | -$508K | ﹤0.01% | 1411 |
|
|
2021
Q4 | $2.42M | Sell |
879,900
-131,500
| -13% | -$362K | 0.01% | 1096 |
|
|
2021
Q3 | $6.07M | Buy |
1,011,400
+21,400
| +2% | +$128K | 0.02% | 698 |
|
|
2021
Q2 | $4.82M | Buy |
990,000
+338,200
| +52% | +$1.65M | 0.01% | 877 |
|
|
2021
Q1 | $1.61M | Buy |
651,800
+602,000
| +1,209% | +$1.49M | ﹤0.01% | 1382 |
|
|
2020
Q4 | $136K | Sell |
49,800
-53,300
| -52% | -$146K | ﹤0.01% | 2231 |
|
|
2020
Q3 | $159K | Buy |
+103,100
| New | +$159K | ﹤0.01% | 2203 |
|
|
2019
Q2 | – | Sell |
-20,000
| Closed | -$28K | – | 2332 |
|
|
2019
Q1 | $28K | Buy |
+20,000
| New | +$28K | ﹤0.01% | 2250 |
|
|
2018
Q2 | – | Sell |
-11,400
| Closed | -$122K | – | 2379 |
|
|
2018
Q1 | $122K | Buy |
+11,400
| New | +$122K | ﹤0.01% | 2209 |
|